Brad Calvin is the CEO and co-founder of AsedaSciences. He has a broad, multidimensional business background with expertise in healthcare inclusive of diagnostics, devices and life sciences across diverse technologies and markets. During his thirty-year tenure in the healthcare industry, Calvin has held various executive level positions in general management, global commercial operations, marketing, sales and business development. Calvin has developed broad expertise across multiple disciplines and geographies, managing commercialization strategies, business operations and R&D on a global scale for companies such as Abbott, Digene, Beckman Coulter and most recently MaxCyte. He understands the workings of organizations from small start-ups to large, complex corporations. Calvin has demonstrated success at turning around under-performing operations and leading start-up businesses, global and regional commercialization strategies and product development in regulated markets.